Pharma

Allogeneic therapies are game-changing in the field of cell therapy, overcoming current critical barriers around cost, production, and accessibility currently faced with autologous, personalized treatments. With billions of pounds worth of investment seen in collaborations to advance the development of allogeneic CAR-T, NK, macrophage and iPSC-based therapies, the excitement in this space is explosive! Capitalizing on this “holy grail” approach at the 4th Allogeneic Cell Therapies Summit, the leading industry-focused meeting captured cutting-edge advances across pre-clinical development, translation, manufacturing, supply and storage, to accelerate the successful clinical translation of your allogeneic pipeline. This fast-evolving community compared and contrasted platform technology to improve durability and persistence, review the strategies for selecting gold-standard donor starting material, and learn about the latest developments in gene engineering and serve as the “off-the-shelf” ready-to-use therapeutic agents for large-scale clinical applications. Over 300 experts from pharma, biotech and leading academia united in Boston to collaborate and share lessons learned to streamline scalable manufacturing processes, define optimal cryopreservation conditions and define regulatory expectations to achieve the huge demand for these treatments.2022 showcased the work of Allogene, Atara Biotherapeutics, Cellectis, Celularity, ImmunityBio, and more, don’t miss out on the most important meeting of the cell therapy calendar in 2023.

ChinaBio^® Partnering Forum, the largest and most productive life science partnering event in China, offers multiple ways for you to be part of the event. Explore the options below to learn more about how you can get involved.

Biotech Showcase provides biotechnology companies, pharmaceutical executives and investors an opportunity to meet in one place during the world’s largest annual healthcare investor conference.

Over the past 10 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI’s IO Summit provides.

Where the new wave of life science innovators partner to fuel the future of drug development.

We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches. Learn from industry, academia and the FDA at 3 Conference Programs, Symposium, Training Seminar, Workshop and 5 Short Courses. Once again, we’ll host interactive breakouts on various niche topics so delegates can share experiences and generate new ideas. 

BIO-Europe Spring, the premier springtime partnering event, brings together over 3,700 attendees from 2,000+ companies to engage in 20,000 one-to-one meetings.

Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one’s interests by going back and forth among concurrent tracks.

DPHARM is designed for drug development innovative thinkers who are determined to re-invent clinical trials. Going into its fifteenth year, the conference explores how clinical trials can be reimagined to be more efficient, more patient-focused, more accurate, quicker and less costly.  The conference has become highly regarded among executives at Pharma companies, Biotechs and CROs.

DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forwardthinking approaches for implementing digital technology to improve clinical trials.